A Neurotrophic & Nootropic Formulation with BDNF and NGF mRNA Expression Enhancement Features for the Treatment of Neurological Damage & Development Disorders BDNF NGF Neurotrophin

Description

A Neurotrophic and Nootropic Formulation consisting of a Pro-Somathropic Dioscin Analouge with increased systemic duration due to prolonged half-life, a Gymnemic Acid Analouge with BDNF NGF and Neurotrophin B3 mRNA Expression Enhancing Properties. Formulation may serve as an adjuvant curative means for Neurological Development Defects along with Chronical Cerebrospinal Ailments like Dementia, Neuromascular Defects and other Neurodegenerative Disorders.

Author

This dataset has been published on the initiative and under the responsibility of Erdal Can Alkoclar
Published on April 23, 2020 and updated on September 1, 2021

Latest update

April 23, 2020

License

Creative Commons Attribution Share-Alike 4.0

Metadata quality
44.0%

Files documentation missing

Update frequency not followed

File formats are closed

Temporal coverage not set

Spatial coverage not set

There are no reuses for this dataset yet.

Publish a reuse What's a reuse ?

There are no discussions for this dataset yet.

There are no community resources for this dataset yet.

Share your resources Learn more about the community

Information

Temporality

Creation

April 23, 2020

Frequency

Biannual

Latest update

April 23, 2020

Actions

Embed